Carminia Maria Della Corte

Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities

Carl M. Gay, C. Allison Stewart, Elizabeth M. Park et al. · Cancer Cell · 2021 · 932 citations · Full text

Medicine, Cancer Biology, Molecular Biology +10

Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer

Triparna Sen, B. Leticia Rodriguez, Limo Chen et al. · Cancer Discovery · 2019 · 881 citations · Full text

Life Sciences, Immunology, Oncology +17

STING Pathway Expression Identifies NSCLC With an Immune-Responsive Phenotype

Carminia Maria Della Corte, Triparna Sen, Carl M. Gay et al. · Journal of Thoracic Oncology · 2020 · 204 citations · Full text

Life Sciences, Immunology, Molecular Biology +12

SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer

Carminia Maria Della Corte, Claudio Bellevicine, Giovanni Vicidomini et al. · Clinical Cancer Research · 2015 · 119 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironment in SCLC

Triparna Sen, Carminia Maria Della Corte, Snezana Milutinovic et al. · Journal of Thoracic Oncology · 2019 · 119 citations · Full text

Medicine, Oncology, Pharmacology +17